Application
Western blot analysis of CSGALNACT2 Antibody (Center) in 293 cell line lysates (35ug/lane). CSGALNACT2 (arrow) was detected using the purified Pab.Application
Formalin-fixed and paraffin-embedded human hepatocarcinoma reacted with CSGALNACT2 Antibody (Center), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.Application
CSGALNACT2 Antibody (Center) flow cytometric analysis of 293 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | CSGALNACT2 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | CSGALNACT2; CHGN2; GALNACT2; Chondroitin sulfate N-acetylgalactosaminyltransferase 2; Chondroitin beta-1, 4-N-acetylgalactosaminyltransferase 2 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHCFC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | CHGN2 GALNACT2 |
|---|---|
| Alternative Names | CSGALNACT2 CHGN2 GALNACT2 Chondroitin sulfate N-acetylgalactosaminyltransferase 2 Chondroitin beta-1 4-N-acetylgalactosaminyltransferase 2 |
| Molecular Weight(MW) | 62572 Da |
| Function | Transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP- GalNAc to the non-reducing end of glucuronic acid (GlcUA) Required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains |
| Tissue Specificity | Ubiquitous. |
| Cellular Localization | Golgi apparatus, Golgi stack membrane; Single-pass type II membrane protein (Probable) |
| Entrez Gene | 55454 |
|---|
Application
Western blot analysis of CSGALNACT2 Antibody (Center) in 293 cell line lysates (35ug/lane). CSGALNACT2 (arrow) was detected using the purified Pab.
Application
Formalin-fixed and paraffin-embedded human hepatocarcinoma reacted with CSGALNACT2 Antibody (Center), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.
Application
CSGALNACT2 Antibody (Center) flow cytometric analysis of 293 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
